Phase 2 Stroke Trial, Recruiting NCT07113067 Sponsor: Medical University of South Carolina Condition: Stroke
Back to Stroke

Phase 2 Stroke Trial, Recruiting

NCT07113067
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 40 years old or older
  • You have had a stroke (either a bleeding stroke or a blocked blood vessel stroke) in either side of the brain, and it happened at least 6 months ago
  • You have been confirmed to have significant apathy (lack of motivation or interest) based on a standard questionnaire score — either completed by you or your caregiver
  • You are able to take part in memory and thinking tests
  • The area of your brain being targeted in this study is undamaged, as confirmed by an MRI scan before treatment
  • You have a caregiver or support person who is able to take part in the study alongside you

Who may not be able to join:

  • Your stroke was only a bleed around the outside of the brain (such as a subdural or subarachnoid hemorrhage) without any other type of stroke
  • You have another brain or nervous system condition that affects your movement or thinking, such as dementia
  • You have moderate or severe difficulty with language due to your stroke
  • Your vision problems would prevent you from completing the thinking and memory tasks
  • You have a medical implant that is not compatible with MRI or the brain stimulation used in this study, such as a pacemaker or certain metal implants
  • You are pregnant, or if there is a chance you could be pregnant, this will be checked before you take part
  • You have a history of seizures or epilepsy
  • You have a wound, skin problem, bone defect, or a section of skull that was surgically removed on your scalp or head
  • You feel very uncomfortable in enclosed spaces (claustrophobia) in a way that would stop you from having an MRI scan
  • You are currently struggling with a substance use disorder (such as alcohol or drug dependency)
  • You have a condition involving psychosis
  • You have Bipolar 1 Disorder
  • You are currently having thoughts of suicide or have made a suicide attempt in the past year

For the caregiver/support person — who can take part:

  • They are 18 years old or older
  • They are in regular contact with you at least once a week and can give reliable information about how you are thinking and managing day-to-day life
  • They are able to take part in the parts of the study that require their involvement (if they cannot engage with these, they may not be eligible)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Parneet Grewal, PhD, Medical University of South Carolina

Phone: 843-792-3020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
8 August 2025
Est. completion
30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in apathy symptoms, as measured by the Lille Apathy Rating Scale (LARS) compared to baseline; Change in apathy symptoms as measured by the Apathy Evaluation Scale (AES) - Self and Informant Versions; Incidence of Treatment-Emergent Adverse Events and Side Effects as assessed by change in the Review of Systems Criteria compared to baseline; Change From Baseline Cognition, as Measured by the Fluid Cognition Composite Score From the NIH Toolbox Cognition Battery compared to baseline; Participant retention rate; Patient perception of treatment acceptability as assessed by study-specific que...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov